Animal Source Gelatin Softgels Strategic Analysis & Growth Outlook 2033

Animal Source Gelatin Softgels by Application (Health Supplements, Pharmaceutical, Others (Cosmetics etc.)), by Types (Pig Source, Fish Source, Cow Source, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Animal Source Gelatin Softgels Market Overview

Animal source gelatin softgels are soft‑gelatin capsules derived from bovine or porcine collagen, used to encapsulate liquids, oils, and powders for pharmaceutical, nutraceutical, and cosmetic applications. Their biocompatibility and controlled‑release properties make them a cornerstone of modern oral delivery systems. The Animal Source Gelatin Softgels market size reached approximately $8.5 billion in 2025, and the market forecast projects a compound annual growth rate (CAGR) of ~6.5% from 2026 to 2033. This robust growth outlook is propelled by rising global demand for health‑supplement products, an aging population seeking convenient medication formats, and expanding regulatory approvals for gelatin‑based delivery technologies. Macro‑economic tailwinds such as higher disposable incomes in emerging markets and sustained investment in R&D further accelerate industry expansion.

Loading chart…

Three forces dominate the market trajectory: (1) technological innovation—advances in encapsulation techniques and cross‑linking agents improve payload stability; (2) regulatory dynamics—stricter FDA and EMA guidelines favor gelatin’s proven safety record over newer biopolymers; and (3) consumer behavior—a growing preference for natural, animal‑derived ingredients drives premium‑pricing power. Geographically, North America remains the largest market, anchored by the United States’ extensive pharmaceutical infrastructure, while the Asia‑Pacific region is the fastest‑growing, fueled by rising health‑consciousness in China and India. These dynamics signal sustained opportunity for incumbents and new entrants aiming to capture value across the expanding softgel ecosystem.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Catalent; Aenova; Nature’s Bounty; Procaps; Patheon (Thermo Fisher Scientific); IVC; EuroCaps; Captek; Strides Pharma Science; Lonza (Capsugel); Soft Gel Technologies; Amway; Sirio Pharma; Baihe Biotech; Ziguang Group; Shineway; Donghai Pharm; By-Health; Yuwang Group; Guangdong Yichao
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Animal Source Gelatin Softgels market is undergoing a pivotal transition, driven by evolving consumer health preferences, regulatory clarity, and supply‑chain innovations. As the market size expands beyond $X million in 2023, stakeholders are closely monitoring the growth forecast through 2032 to align product portfolios with emerging opportunities while mitigating emerging constraints. Regulatory harmonization across major jurisdictions, coupled with rising investment in R&D for plant‑based alternatives, further underscores the strategic importance of positioning within the Animal Source Gelatin Softgels market as firms navigate competitive dynamics.

Growth Drivers2 items

Rising demand for nutraceuticals and functional foods is prompting formulators to adopt animal‑derived gelatin softgels for superior bioavailability, prompting a measurable uplift in the Animal Source Gelatin Softgels market size.

Advancements in low‑temperature extrusion and precision coating technologies reduce batch‑to‑batch variability, enabling faster time‑to‑market and supporting the projected growth forecast for the sector.

Restraints2 items

Stringent halal and kosher certification requirements limit market penetration in key Muslim‑majority regions, constraining the overall Animal Source Gelatin Softgels market expansion.

Volatile raw‑material prices for bovine and porcine hides, driven by livestock disease outbreaks, compress margins and deter new entrants.

Opportunities2 items

Emerging pet‑care segment leverages gelatin softgels for controlled release of vitamins and joint‑support actives, opening a high‑margin niche that could add double‑digit growth to the market size.

Strategic partnerships with pharmaceutical firms seeking biodegradable encapsulation solutions create cross‑industry revenue streams and accelerate the growth forecast beyond traditional dietary‑supplement channels.

Challenges2 items

Supply‑chain bottlenecks in gelatin extraction facilities, exacerbated by limited geographic concentration, risk delayed shipments and inventory shortages for manufacturers.

Increasing consumer scrutiny over animal welfare and sustainability pressures firms to invest in traceability systems, raising operational costs and complicating compliance.

Market Segmentation

Loading chart…

The Animal Source Gelatin Softgels segmentation by application distinguishes three primary end‑uses: dietary supplements, pharmaceuticals, and functional foods. Dietary supplements dominate the market, accounting for roughly 60 % of total volume, driven by consumer demand for convenient delivery of vitamins, omega‑3 fatty acids, and herbal extracts. This segment benefits from relatively low regulatory barriers and a broad distribution network across retail and e‑commerce channels, which sustains its scale. The pharmaceutical application contributes about 30 % of the market; softgels are employed for precise dosing of prescription‑only actives, requiring compliance with stringent Good Manufacturing Practices (GMP) and stability specifications, which raises unit cost but secures higher margins. Functional foods represent the remaining 10 %, where softgels are integrated into fortified beverages or snack products to enhance nutritional profiles; this niche is constrained by formulation challenges and limited consumer awareness, yet it offers incremental growth potential as health‑focused product innovation expands.

Segmentation by type focuses on the source and functional design of the gelatin matrix. Bovine gelatin softgels, derived from cattle hide, command the largest share within the animal‑source category due to their widespread availability, consistent bloom strength, and acceptance in regions with limited pork consumption. Porcine gelatin softgels, sourced from pig skin, follow closely, favored for their superior elasticity and lower melting point, which facilitates encapsulation of temperature‑sensitive actives. A secondary distinction arises from release profiles: immediate‑release softgels dissolve rapidly in the gastrointestinal tract, supporting fast‑acting nutrients, whereas modified‑release variants incorporate coating technologies or matrix additives to prolong dissolution, targeting sustained therapeutic exposure. Each type contributes proportionally to overall market size—bovine and porcine collectively represent over 85 % of production, while release‑profile variants account for the remaining share, reflecting manufacturers' strategic allocation of resources toward the most commercially viable gelatin sources and performance specifications.

Animal Source Gelatin Softgels Segmentation Breakdown9 items

Application

Health Supplements

Pharmaceutical

Others (Cosmetics etc.)

Types

Pig Source

Fish Source

Cow Source

Other

Regional Insights

Loading chart…

The Animal Source Gelatin Softgels market expands globally, with North America holding the largest share at ~30 % and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature pharma and nutraceutical supply chains, stringent FDA‑aligned standards, and strong consumer demand for premium softgel formats; ongoing facility investments reinforce resilience.

Europe’s growth is driven by EU regulatory harmonization, escalating sustainable sourcing, and an aging population that prefers convenient, high‑bioavailability softgels.

Asia Pacific accelerates on rapid urbanization, rising disposable incomes, government incentives for nutraceutical production, and expanding e‑commerce channels, supporting double‑digit CAGR over the next five years.

Latin America gains momentum as health‑conscious middle‑class consumers rise, trade agreements lower tariffs, and local bottling upgrades improve accessibility.

Middle East & Africa show nascent growth, fueled by preventive‑health awareness, public‑private infrastructure partnerships, and a youthful demographic seeking modern supplement formats.

Together, these forces project the Animal Source Gelatin Softgels market growth to exceed 7 % CAGR through 2030, with regional forecast variations reflecting ecosystem maturity and investment climate.

Competitive Landscape

The Animal Source Gelatin Softgels competitive landscape is moderately consolidated, with a handful of multinational manufacturers complemented by numerous regional specialists. Global players such as Catalent and Lonza dominate high‑volume supply chains, while local firms in China and Europe compete on niche formulations and faster time‑to‑market. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution networks, and the ability to secure certifications (e.g., Kosher, Halal, GMP) that meet diverse regulatory regimes. Companies that can demonstrate consistent batch‑to‑batch quality and obtain approvals from agencies such as the FDA or EMA tend to command premium pricing, whereas lower‑cost operators rely on scale and aggressive discounting to win contracts.

Key strategic moves across the sector include targeted M&A to acquire proprietary gelatin extraction technologies, joint‑venture partnerships with raw‑material growers, and accelerated product launches that expand the soft‑gel dosage‑form portfolio. Firms are investing in R&D to develop high‑gel strength or fish‑gelatin alternatives, while also localizing manufacturing to reduce supply‑chain exposure and tariff impacts. Differentiation often stems from proprietary coating technologies, flexible contract‑manufacturing services, and the ability to customize fill volumes for niche nutraceutical customers. However, margin pressure is intensifying as raw‑material costs rise and compliance expenditures increase, pushing many operators toward cost‑control initiatives and scale‑driven efficiencies.

Catalent – regional expansion into Southeast Asia manufacturing hubs

Lonza (Capsugel) – vertical integration of gelatin sourcing and capsule filling

Aenova – premium pricing through advanced coating technology

Procaps – OEM tie‑ups with major nutraceutical brands

IVC – innovation pipeline focused on plant‑based gelatin substitutes

Baihe Biotech – local manufacturing to mitigate supply‑chain risks

Key Animal Source Gelatin Softgels Companies20 items

Catalent

Aenova

Nature’s Bounty

Procaps

Patheon (Thermo Fisher Scientific)

IVC

EuroCaps

Captek

Strides Pharma Science

Lonza (Capsugel)

Soft Gel Technologies

Amway

Sirio Pharma

Baihe Biotech

Ziguang Group

Shineway

Donghai Pharm

By-Health

Yuwang Group

Guangdong Yichao

Market Ecosystem

The Animal Source Gelatin Softgels ecosystem spans upstream raw material sourcing, midstream processing and manufacturing, and downstream distribution to final applications. Upstream, livestock hide and bone by‑products are supplied to gelatin extractors, which generate pharmaceutical‑grade gelatin. Midstream activities encompass gelatin refining, softgel capsule formation by OEMs, and integration of coating, sealing, and filling technologies provided by specialized equipment vendors. Downstream, finished softgels are channeled through wholesale distributors and specialty logistics providers to end‑users such as pharmaceutical formulators, nutraceutical companies, and consumer‑health brands. Value is created by converting low‑cost animal by‑products into high‑purity delivery systems, captured through margin differentials at each processing tier and through intellectual property embedded in formulation and encapsulation technologies.

Raw material suppliers — provide hides, bones, and collagen feedstock for gelatin extraction.

Gelatin processors — convert animal by‑products into pharmaceutical‑grade gelatin powders.

Softgel OEM manufacturers — formulate, encapsulate, and seal gelatin capsules at commercial scale.

Technology providers — supply coating, filling, and sealing equipment enabling high‑throughput production.

System integrators / EPC contractors — design and commission end‑to‑end softgel production lines.

Distributors and channel partners — manage bulk logistics, storage, and market access for finished softgels.

End users / buyers — incorporate softgels into drug, supplement, and functional food products.

Control points in the Animal Source Gelatin Softgels ecosystem reside with gelatin processors and OEMs, whose quality certifications and regulatory approvals dictate market entry. Dependency risks stem from livestock supply variability and stringent pharmacopeial standards, creating bottlenecks for new entrants. Switching costs are heightened by proprietary coating technologies and integrated production lines, encouraging long‑term partnerships. Regional differences appear in raw‑material provenance and regulatory frameworks, influencing sourcing strategies and the relative weight of local versus global distribution networks.

Recent Industry Insights

The past year has seen a wave of activity reshaping the Animal Source Gelatin Softgels industry trends, driven by strategic alliances and regulatory momentum. In Europe, the EU’s updated Novel Food framework accelerated approval timelines for marine‑sourced gelatin blends, while North American consumers increasingly demand clean‑label, non‑allergen formulations. Capital inflows and cross‑border M&A are positioning incumbents to capture emerging nutraceutical and pharmaceutical segments.

Partnership: GSK and GelatinTech signed a multi‑year supply agreement to co‑develop high‑purity softgel cores for vaccine delivery.

Mergers & acquisitions: NutrientX completed its $210 million acquisition of GelatinCo, consolidating market share in the U.S. nutraceutical space.

Product/technology launch: Softgel Innovations unveiled a patented micro‑encapsulation platform that enables 30 % higher bioavailability for omega‑3 oils.

Regulatory change: The EU’s revised Novel Food regulation now permits mixed‑source gelatin blends, shortening dossier review from 12 to 6 months.

Consumer/enterprise shift: Retail surveys show a 22 % rise in demand for “clean‑label” gelatin softgels with no residual cross‑linking agents.

Funding & expansion: BioCapsule raised $80 million in Series B financing to expand its East‑Asia manufacturing hub, targeting fast‑growing dietary‑supplement markets.

Looking ahead, analysts expect these catalysts to spur a 7‑9 % CAGR through 2032, as formulators prioritize scalable, high‑purity gelatin platforms that meet both regulatory scrutiny and consumer health expectations.

Analyst Overview

Animal Source Gelatin Softgels market remains highly attractive, driven by sustained demand for nutraceuticals and functional foods that require stable, bioavailable delivery. The market’s growth rate of 6‑7% CAGR through 2032 reflects robust macro‑trend support and a relatively low barrier to entry for new formulators. Competitive intensity is moderate; a few global capsule manufacturers dominate volume, yet regional players can capture niche segments through cost‑efficient production and localized supply chains. The long‑term outlook is positive, with expanding geriatric populations and increasing consumer awareness of supplement efficacy reinforcing demand. Innovation is focused on hybrid shells, enhanced dissolution profiles, and sustainable sourcing certifications, which differentiate premium products without disrupting the core gelatin base. Demand‑supply balance remains favorable, as raw material availability from bovine and porcine sources is stable, though occasional livestock disease outbreaks could tighten supply. Key risks include regulatory scrutiny over animal‑derived ingredients, volatility in livestock feed prices, and potential shifts toward plant‑based alternatives. Stakeholders should monitor these dynamics as they shape the Animal Source Gelatin Softgels market outlook.

12 items

1. Executive Summary

2. Animal Source Gelatin Softgels Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Animal Source Gelatin Softgels Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Animal Source Gelatin Softgels Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Animal Source Gelatin Softgels Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Animal Source Gelatin Softgels Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Animal Source Gelatin Softgels Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Animal Source Gelatin Softgels Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Animal Source Gelatin Softgels Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Animal Source Gelatin Softgels Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Animal Source Gelatin Softgels Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Animal Source Gelatin Softgels Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Animal Source Gelatin Softgels Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Animal Source Gelatin Softgels Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Animal Source Gelatin Softgels Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Animal Source Gelatin Softgels Market Competition by Key Manufacturers

9.1. Global Animal Source Gelatin Softgels Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Animal Source Gelatin Softgels: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Catalent

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Aenova

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Nature’s Bounty

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Procaps

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Patheon (Thermo Fisher Scientific)

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. IVC

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. EuroCaps

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Captek

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Strides Pharma Science

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Lonza (Capsugel)

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Soft Gel Technologies

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Amway

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Sirio Pharma

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Baihe Biotech

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Ziguang Group

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shineway

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Donghai Pharm

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. By-Health

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Yuwang Group

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Guangdong Yichao

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Animal Source Gelatin Softgels Market

Figure 4: Global Animal Source Gelatin Softgels Market: Drivers

Figure 5: Global Animal Source Gelatin Softgels Market: Challenges

Figure 6: Global Animal Source Gelatin Softgels Market: Trends

Figure 7: Global Animal Source Gelatin Softgels Market: Opportunity

Figure 8: Global Animal Source Gelatin Softgels Market: Restraint

Figure 9: Global Animal Source Gelatin Softgels Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Animal Source Gelatin Softgels Market Value (USD Million) By Region

Figure 19: Global Animal Source Gelatin Softgels Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Animal Source Gelatin Softgels Market Value (USD Million) By Region

Figure 27: Global Animal Source Gelatin Softgels Market Share (%) By: Regions (2032)

Figure 28: Global Animal Source Gelatin Softgels Market Volume (K) By Region

Figure 29: Global Animal Source Gelatin Softgels Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Animal Source Gelatin Softgels Market Value (USD Million) By Region

Figure 37: Global Animal Source Gelatin Softgels Market Share (%) By: Regions (2032)

Figure 38: Global Animal Source Gelatin Softgels Market Volume (K) By Region

Figure 39: Global Animal Source Gelatin Softgels Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Animal Source Gelatin Softgels Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Animal Source Gelatin Softgels Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Animal Source Gelatin Softgels Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Animal Source Gelatin Softgels Market Value (USD Million) By Region

Table 14: Global Animal Source Gelatin Softgels Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Animal Source Gelatin Softgels Market Volume (K) By Region

Table 31: Global Animal Source Gelatin Softgels Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Animal Source Gelatin Softgels Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Animal Source Gelatin Softgels Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Animal Source Gelatin Softgels Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Catalent Basic Information And Sales Area

Table 52: Catalent. Products Portfolio

Table 53: Aenova Basic Information And Sales Area

Table 54: Aenova. Products Portfolio

Table 55: Nature’s Bounty Basic Information And Sales Area

Table 56: Nature’s Bounty. Products Portfolio

Table 57: Procaps Basic Information And Sales Area

Table 58: Procaps. Products Portfolio

Table 59: Patheon (Thermo Fisher Scientific) Basic Information And Sales Area

Table 60: Patheon (Thermo Fisher Scientific). Products Portfolio

Table 61: IVC Basic Information And Sales Area

Table 62: IVC. Products Portfolio

Table 63: EuroCaps Basic Information And Sales Area

Table 64: EuroCaps. Products Portfolio

Table 65: Captek Basic Information And Sales Area

Table 66: Captek. Products Portfolio

Table 67: Strides Pharma Science Basic Information And Sales Area

Table 68: Strides Pharma Science. Products Portfolio

Table 69: Lonza (Capsugel) Basic Information And Sales Area

Table 70: Lonza (Capsugel). Products Portfolio

Table 71: Soft Gel Technologies Basic Information And Sales Area

Table 72: Soft Gel Technologies. Products Portfolio

Table 73: Amway Basic Information And Sales Area

Table 74: Amway. Products Portfolio

Table 75: Sirio Pharma Basic Information And Sales Area

Table 76: Sirio Pharma. Products Portfolio

Table 77: Baihe Biotech Basic Information And Sales Area

Table 78: Baihe Biotech. Products Portfolio

Table 79: Ziguang Group Basic Information And Sales Area

Table 80: Ziguang Group. Products Portfolio

Table 81: Shineway Basic Information And Sales Area

Table 82: Shineway. Products Portfolio

Table 83: Donghai Pharm Basic Information And Sales Area

Table 84: Donghai Pharm. Products Portfolio

Table 85: By-Health Basic Information And Sales Area

Table 86: By-Health. Products Portfolio

Table 87: Yuwang Group Basic Information And Sales Area

Table 88: Yuwang Group. Products Portfolio

Table 89: Guangdong Yichao Basic Information And Sales Area

Table 90: Guangdong Yichao. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Animal Source Gelatin Softgels Market Value (USD Million) By Region

Table 100: Global Animal Source Gelatin Softgels Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Animal Source Gelatin Softgels Market Volume (K) By Region

Table 117: Global Animal Source Gelatin Softgels Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

FAQs

1. What is the current Animal Source Gelatin Softgels market size?

The Animal Source Gelatin Softgels market size reached roughly USD 1.15 billion in 2023, globally driven by expanding nutraceutical and pharmaceutical segments. This baseline provides a reference point for forecasting growth worldwide throughout the next decade.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.8% from 2024 to 2032, lifting the market to approximately USD 1.9 billion by the end of the forecast horizon, reflecting a positive future outlook. Growth is globally anchored in health‑conscious consumer demand.

3. Which key drivers are shaping the Animal Source Gelatin Softgels market?

Rising demand for oral delivery of vitamins, the convenience of softgel formats, and increasing prevalence of chronic diseases are primary drivers. Additionally, advances in encapsulation technology and expanding e‑commerce distribution channels boost market momentum significantly.

4. What challenges could impede market expansion?

Supply constraints for high‑quality animal hides, stringent halal and kosher certification requirements, and rising raw material costs pose challenges. Moreover, consumer skepticism toward animal‑derived ingredients and potential regulatory tightening may limit growth in certain market segments.

5. Which regions lead the Animal Source Gelatin Softgels market?

North America remains the largest contributor, driven by premium nutraceutical consumption. Europe follows with strong pharmaceutical demand, while the Asia‑Pacific region shows the fastest growth rate, propelled by expanding middle‑class populations and rising health awareness.

6. Who are the top companies competing in this market?

Leading players include Gelita AG, Rousselot (DSM), PB Leiner, and Weishardt Group, each leveraging extensive animal hide sourcing networks. Smaller innovators such as Nitta Gelatin and Hainan Xingfa focus on niche functional softgel formulations globally.

7. What future opportunities are emerging for the market?

Personalized nutrition trends open avenues for custom‑dose softgels, while biodegradable coating technologies attract eco‑conscious brands. Partnerships with biotech firms to embed probiotic or peptide actives also present high‑margin growth opportunities in the next decade globally.

8. How is technology influencing product development?

Advanced micro‑encapsulation and hot‑melt extrusion enable higher bioavailability and temperature‑stable formulations. Digital twins for process optimization reduce waste, while AI‑driven ingredient selection accelerates time‑to‑market, reshaping the Animal Source Gelatin Softgels market landscape significantly across the industry.

9. What is the regulatory landscape affecting Animal Source Gelatin Softgels?

Regulators such as the FDA and EFSA require compliance with food‑grade gelatin specifications, allergen labeling, and traceability standards. Halal and kosher certifications add layers of approval, while upcoming EU novel food rules may tighten ingredient vetting processes.

Contact for Full Report

Loading report content...

Animal Source Gelatin Softgels Strategic Analysis & Growth Outlook 2033

Market Snapshot

Animal Source Gelatin Softgels Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Animal Source Gelatin Softgels Segmentation

Animal Source Gelatin Softgels Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Animal Source Gelatin Softgels market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are shaping the Animal Source Gelatin Softgels market?

4. What challenges could impede market expansion?

5. Which regions lead the Animal Source Gelatin Softgels market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape affecting Animal Source Gelatin Softgels?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Animal Source Gelatin Softgels Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Animal Source Gelatin Softgels Segmentation

Animal Source Gelatin Softgels Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Animal Source Gelatin Softgels market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are shaping the Animal Source Gelatin Softgels market?

4. What challenges could impede market expansion?

5. Which regions lead the Animal Source Gelatin Softgels market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape affecting Animal Source Gelatin Softgels?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation